Skip to main content
    C

    Cronos Group Inc (CRON)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $3.27
    -0.11 (-3.25%)

    Market Cap: $1.24B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Cronos Group Inc (CRON) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Cronos Group (CRON) trades at 28.4x trailing earnings and 5.6x sales. Its P/S of 5.6x is below its 5-year median of 8.7x. Its forward P/E is 22.8x. The median P/E across 10 similar companies is 10.5x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 24.6% higher over the next year. Its free cash flow yield is 5.5%.

    MultipleValue
    P/E (trailing)28.4x
    Forward P/E22.8x
    Price to sales5.6x
    Price to book1.1x
    EV/EBITDA20.1x
    Price to FCF18.3x
    EV/FCF12.0x
    PEGN/A
    FCF yield5.5%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 73.6% below 21.2x and its P/B is in line.

    MultipleCurrent5-year median10-year median
    P/S5.6x8.7x21.2x
    P/B1.1x0.9x1.1x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 117 to 120 months (10-year).

    Valuation History

    Over the 3 of the 10 year ends shown that have a P/E, its P/E ranged from 12.7x in 2024 to 191.8x in 2019.

    Year endPriceP/EP/SP/B
    2025$2.63104.0x6.9x0.9x
    2024$2.0212.7x6.6x0.7x
    2023$2.09N/A9.1x0.7x
    2022$2.54N/A11.1x0.8x
    2021$3.92N/A22.5x1.1x
    2020$6.94N/A44.8x1.4x
    2019$7.67191.8x106.4x2.2x
    2018$10.39N/A162.3x9.1x
    2017$7.73N/A293.0x15.2x
    2016$1.10N/AN/A2.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CRON

    What is CRON's forward P/E ratio?

    Cronos Group has a forward P/E ratio of 22.8x.

    Is CRON stock overvalued?

    GNG's valuation label for CRON is Undervalued. Its P/E of 28.4x compares with a median of 10.5x across 10 similar companies.

    What is CRON's price to sales ratio?

    Cronos Group has a price to sales ratio of 5.6x.